A set of validated biomarkers for early detection of diabetic nephropathy

Title: We have screened the markers in patient samples of diabetic nephropathy. The patients were graded according to their stage of diabetes and nephropathy and screened for early markers and compared with known classical markers.Our study identified 3 markers which in conjunction can act as reliable indicators of early stage of diabetes associated nephropathy. We are now proceeding with a patent filing and validation of these markers in a larger patient cohort.

Innovator: CSIR-Indian Institute of Toxicology Research

USP: A point of care diagnostic system for early detection of diabetic nephropathy. Highly useful for people with diabetes and related complication.

  • Innovator's Name
  • Product/Technology Description

CSIR-Indian Institute of Toxicology Research

  • Product Name: A set of validated biomarkers for early detection of diabetic nephropathy
  • Product Title: We have screened the markers in patient samples of diabetic nephropathy. The patients were graded according to their stage of diabetes and nephropathy and screened for early markers and compared with known classical markers.Our study identified 3 markers which in conjunction can act as reliable indicators of early stage of diabetes associated nephropathy. We are now proceeding with a patent filing and validation of these markers in a larger patient cohort.
  • Description:
  • Unique Selling Point: A point of care diagnostic system for early detection of diabetic nephropathy. Highly useful for people with diabetes and related complication.
Color: